A detailed history of Portfolio Design Labs, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Portfolio Design Labs, LLC holds 37,706 shares of BMY stock, worth $2.19 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
37,706
Holding current value
$2.19 Million
% of portfolio
0.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $1.5 Million - $1.95 Million
37,706 New
37,706 $1.95 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Portfolio Design Labs, LLC Portfolio

Follow Portfolio Design Labs, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portfolio Design Labs, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portfolio Design Labs, LLC with notifications on news.